Substituted-1-phthalazinamines as vr-1 antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/04 (2006.01) A61K 31/502 (2006.01) A61K 31/5025 (2006.01) C07D 403/04 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2524622

The present invention provides a compound of formula (I): in which Ar and R1 are phenyl or a heteroaromatic group, R2 is generally hydrogen, R3 is hydrogen or alkyl and X, Y and Z are generally CH or N as VR-1 antagonists; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising it; its use in therapy; use of it to manufacture medicaments to treat pain or inflammation; and methods of treating pain or inflammation.

Composé de formule (I) dans laquelle Ar et R?1¿ représentent phényle ou un groupe hétéroaromatique, R?2¿ représente généralement hydrogène, R?3¿ représente hydrogène ou alkyle et X, Y et Z représentent généralement CH ou N, en tant qu'antagonistes de VR-1, ou sel acceptable sur le plan pharmaceutique dudit composé, compositions pharmaceutiques contenant ce composé, son utilisation en thérapie, son utilisation pour produire des médicaments destinés à traiter la douleur ou l'inflammation et méthodes de traitement de la douleur ou de l'inflammation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted-1-phthalazinamines as vr-1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted-1-phthalazinamines as vr-1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted-1-phthalazinamines as vr-1 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1487427

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.